TGA
- Status: likely_approved
🇦🇺 Sunpg 1622 in Australia
Sunpg 1622 (TILDRAKIZUMAB) regulatory status in Australia.
Marketing authorisations
TGA
- Status: likely_approved
Sunpg 1622 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Australia
Frequently asked questions
Is Sunpg 1622 approved in Australia?
Yes. TGA has authorised it; TGA has authorised it.
Who is the marketing authorisation holder for Sunpg 1622 in Australia?
Sun Pharma Global is the originator. The local marketing authorisation holder may differ — check the official source linked above.